1. Home
  2. CSCI vs DSS Comparison

CSCI vs DSS Comparison

Compare CSCI & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSCI
  • DSS
  • Stock Information
  • Founded
  • CSCI 1990
  • DSS 1984
  • Country
  • CSCI Canada
  • DSS United States
  • Employees
  • CSCI N/A
  • DSS N/A
  • Industry
  • CSCI
  • DSS Containers/Packaging
  • Sector
  • CSCI
  • DSS Consumer Discretionary
  • Exchange
  • CSCI NYSE
  • DSS Nasdaq
  • Market Cap
  • CSCI 9.9M
  • DSS 8.0M
  • IPO Year
  • CSCI 1996
  • DSS N/A
  • Fundamental
  • Price
  • CSCI $3.34
  • DSS $0.95
  • Analyst Decision
  • CSCI
  • DSS
  • Analyst Count
  • CSCI 0
  • DSS 0
  • Target Price
  • CSCI N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • CSCI 4.3K
  • DSS 14.4K
  • Earning Date
  • CSCI 05-13-2025
  • DSS 05-27-2025
  • Dividend Yield
  • CSCI N/A
  • DSS N/A
  • EPS Growth
  • CSCI N/A
  • DSS N/A
  • EPS
  • CSCI N/A
  • DSS N/A
  • Revenue
  • CSCI $9,030,000.00
  • DSS $19,097,000.00
  • Revenue This Year
  • CSCI N/A
  • DSS N/A
  • Revenue Next Year
  • CSCI N/A
  • DSS N/A
  • P/E Ratio
  • CSCI N/A
  • DSS N/A
  • Revenue Growth
  • CSCI 127.46
  • DSS N/A
  • 52 Week Low
  • CSCI $1.96
  • DSS $0.72
  • 52 Week High
  • CSCI $11.10
  • DSS $1.94
  • Technical
  • Relative Strength Index (RSI)
  • CSCI N/A
  • DSS 51.89
  • Support Level
  • CSCI N/A
  • DSS $0.80
  • Resistance Level
  • CSCI N/A
  • DSS $0.99
  • Average True Range (ATR)
  • CSCI 0.00
  • DSS 0.08
  • MACD
  • CSCI 0.00
  • DSS -0.00
  • Stochastic Oscillator
  • CSCI 0.00
  • DSS 82.14

About CSCI COSCIENS BIOPHARMA INC

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

Share on Social Networks: